Myeloma

Since my diagnosis with multiple myeloma, I try to keep inspired to keep moving forward despite the challenges.

Boruzu, an injectable presentation of Velcade, has been approved by the FDA for patients who either have multiple myeloma or mantle cell lymphoma.

Three years after the first FDA approval of CAR-T cell therapy, patients with multiple myeloma are starting to see the therapy emerge in earlier lines.

CAR-T cell therapy is moving to earlier lines of multiple myeloma treatment.

As soon as I entered complete remission for multiple myeloma, I felt a glimmer of hope.

Patients with multiple myeloma now have several available treatment options, so it’s important to have answers to some of the frequently asked questions.

I was diagnosed with stage 1 multiple myeloma in 2018 and writing poetry helped me work through feelings of anger and acceptance.

Questions about multiple myeloma regarding treatment options, bone strength and other associated comorbidities were answered by an expert.

After my myeloma diagnosis, each day is my own personal Olympics, filled with trials and triumph.

The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for select patients newly diagnosed with multiple myeloma.

From finding reputable info to asking, “Do I really need all these drugs?” experts weighed in on important questions to ask after a myeloma diagnosis.

When I fell in love, I didn’t know my husband would end up getting cancer, but I also glad I learned that normal people like me can make a difference.

“Patients did great” with a four-drug regimen for multiple myeloma, an expert told CURE®.

I decided to receive CAR-T cell therapy for multiple myeloma when my previous regimen stopped working and now, I'm living my best life.

From a TODAY contributor opening up about breast reconstruction surgery to Arizona rep. Raúl Grijalva completing cancer treatment, here’s what’s going on in the oncology space this week.

I was diagnosed with myeloma more than two decades ago and am lucky to have support throughout.

Side effects from multiple myeloma, such as six inches of collapsed vertebrae, have made me adjust my lifestyle, but I make the most of what I can.

One expert explains how bispecific antibodies are a ‘targeted and effective’ option for patients with multiple myeloma.

Treatment with the CAR-T cell therapy Carvykti has been reported to improve survival among some patients with multiple myeloma.

"For their love, support and kindness, I am eternally grateful and blessed to have such people in our lives," said Levinson.

A beautiful tapestry reminded me to stay positive, even during a challenging time with cancer.

From Don Omar announcing being cancer free to “General Hospital” star John York talking about treatment for his two cancers, here’s what’s going on in the oncology space this week.

During the CURE® Educated Patient® Multiple Myeloma Summit, one expert explained the push to make CAR-T cell therapy available for patients sooner.

One expert explains why double autologous stem cell transplantation is a viable alternative to back-to-back transplant in high-risk multiple myeloma.

Data show that patients’ multiple myeloma still fails to progress if patients receive less-frequent Tecvayli.